Molecular Therapeutics®
“Innovations In Microbial Control”
Molecular Therapeutics®
“Innovations In Microbial Control”
Copyright 2017. All Rights Reserved
43-year-old female presented with a herpes-related dermatitis (Shingles) that did not respond to 2 weeks of traditional supportive therapy (Zovirax, Gentamicin and Fambiz). Patient started twice a day use of Silvaklenz and Silvion and the lesions resolved in 5 days.
Day of Presentation
Day 2
Day 3
Day 5
Herpes Related Dermatitis (Shingles) - Clinical Case
Molecular Therapeutics, Silvion, SilvaKlenz, Potentiator and Potentiated are registered trademarks.
Molecular Therapeutics, LLC 111 Riverbend Rd, Suite 264 Athens, GA 30602